Fig. 6: Mapping of materials used for in situ TE vascular grafts per species. | npj Regenerative Medicine

Fig. 6: Mapping of materials used for in situ TE vascular grafts per species.

From: Animal studies for the evaluation of in situ tissue-engineered vascular grafts — a systematic review, evidence map, and meta-analysis

Fig. 6: Mapping of materials used for in situ TE vascular grafts per species.

Relative size represents number of studies using the specific material type. Blended materials are separated by /, and different graft layers are separated by +. Abbreviations: PHEA a,b-poly(N-2-hydroxyethyl)-D,L-aspartamide, CE-Upy Chain extended-ureido-pyrimidinone, PTX Paclitaxel, PBF poly(2,3-butylene furmarate), PMEH poly(2-methacryloyloxyethyl phosphorylcholine-co-2-Ethylhexyl methacrylate), PUSN poly(ester urethane)urea with disulfide and amino group, PetU poly(ether)urethane, P(LA-co-GA) poly(lactid acid-co-glycolic acid), P(LLA-co-CL) poly(L-Lactic-co-caprolactone), P(BT-block-EG) poly(polybutylene terephthalate-co-polyether glycol), PA polyamide/nylon, PCL polycaprolactone, PCU polycarbonate urethane, PDMS polydimethylsiloxane, PDS polydioxanone, PDLA poly-D-L-lactic acid, PEU polyesterurethane, PEUU polyesterurethane urea, PEG polyethylene glycol, PGA polyglycolic acid, PGS polyglycerol sebacate, PLLA poly-l-lactic acid, PU polyurethane, PVA polyvinyl alcohol, SE synthetic elastin.

Back to article page